An upcoming clinical research study is evaluating an investigational vaccine designed to help prevent illness caused by norovirus in adults age 60 and older. Join our interest list to learn more and receive updates when enrollment opens.
Norovirus Vaccine Study – Adults 60+
Age Range:
60 to 100
Gender:
Male and Female
Location:
Rochester, New York
About the Study
Norovirus is a common cause of stomach illness that can lead to symptoms such as nausea, vomiting, diarrhea, and stomach pain. This Phase 3 study is evaluating the safety and effectiveness of an investigational vaccine designed to help prevent moderate or severe illness caused by norovirus.
Complete the form to join our interest list and receive updates about this upcoming norovirus vaccine study.
A member of our study team may contact you when enrollment opportunities become available to provide more information.
Qualifications
You May Qualify If You:
- Are 60 years of age or older
- Are interested in participating in norovirus vaccine research
- Are willing and able to complete study visits and follow-up activities
Additional eligibility requirements will apply.
FEATURED STUDIES
An upcoming clinical research study is evaluating an investigational treatment designed to help prevent the flu in adults who may […]
An upcoming clinical research study is evaluating an investigational vaccine designed to help prevent illness caused by norovirus in adults […]
An upcoming clinical research study is evaluating an investigational long-acting approach designed to help prevent influenza. Join our interest list […]
Adults 65 and older may qualify for a clinical research study evaluating an investigational seasonal flu vaccine.
This clinical trial will help us learn if receiving another dose of the RSV vaccine is safe and can help […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]